HealthKois, a new investment firm focused on healthcare, has launched a fund targeting $300 million, with an additional $100 million green shoe option. This move aims to strengthen India’s healthcare investment sector.
The firm is led by Charles Janssen, Ajay Mahipal, and Dr. Pinak Shrikhande, who previously managed HealthQuad. HealthKois plans to invest between $7 million and $25 million in early growth-stage companies over the next four years.
Their focus areas include healthtech, life sciences, medtech, healthcare delivery, and climate health. The goal is to back companies that improve clinical outcomes and build sustainable healthcare infrastructure.
Charles Janssen said HealthKois will support technology-driven healthcare firms that improve access, affordability, and quality of care. The firm has access to over 75% proprietary deal flow, allowing it to use its networks and expertise to generate strong financial and social returns.
Ajay Mahipal emphasized that HealthKois aims to scale businesses that combine purpose with performance. The firm works closely with founders, offering strategic advice and sector knowledge to help them grow.
Dr. Pinak Shrikhande highlighted that true healthcare innovation comes from empathy, evidence, and execution. HealthKois seeks companies that deliver real clinical and operational results.
HealthKois builds on the success of HealthQuad Funds I and II, which have impacted over 90 million lives and serve more than 8 million patients yearly. While the earlier funds will continue as planned, HealthKois marks a new phase in advancing healthcare innovation in India and other low- and middle-income countries.
